Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by Gooseybearon Aug 02, 2022 2:05pm

369 Views

Post# 34866297

Bristol Myers Squibb in bladder cancer space.

I just received an email from the Bladder Cancer institute regarding a drug trial being performed by Bristol Myers Squibb. I didn't know that this bid pharma was in the bladder cancer space. I took the questionnaire regarding eligibility and I came through the screening positive for 43 possible trials. I have had T1 NMIBC CIS treated with BCG and currently NED.

<< Previous

Bullboard Posts

Next >>

Cannara reports record growth and profitability in Q4 2023